Leading Pharma
PrivateLast Round
Growth Equity
Dec 28, 2017
Total Funding Raised
$40M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Leading Pharma operates in Healthcare & Life Sciences and is based in Fairfield, New Jersey. Its latest recorded funding round was a Growth Equity round in December 2017.
Leading Pharma is a pharmaceutical company that develops, manufactures, and distributes generic pharmaceutical products across a wide range of therapeutic areas.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Compliance, Quality Management
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Leading Pharma Comparables
Compare Leading Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Humanwell Healthcare Group Co Ltd | 89% | |
| Sunrise Pharmaceutical, Inc | 87% | |
| Quagen Pharmaceuticals LLC | 86% |
For institutional investors. Book with your work email.
Leading Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Dec 28, 2017 | ||||
| M&A | Dec 31, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Leading Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Signet Healthcare Partners | Growth Equity |
| Cane Investment Partners | Growth Equity |
| Crestline Investors | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 89% MoM.
- Mar 20, 2026
9,384 bottles of Furosemide tablets recalled nationwide due to quality deviation.
For institutional investors. Book with your work email.
Leading Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Leading Pharma's valuation, stock price, and market status.
Is Leading Pharma a public or private company?
Leading Pharma is a private company.
What is the current stock price of Leading Pharma?
Leading Pharma is a private company, so its shares have no public market price. Caplight tracks Leading Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Leading Pharma worth (valuation)?
Valuation information for Leading Pharma is not publicly available.
Can I buy Leading Pharma stock?
Leading Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Leading Pharma's last funding round?
Leading Pharma's most recent funding round was Growth Equity on December 28, 2017.
Who are the main investors in Leading Pharma?
Key investors in Leading Pharma include Signet Healthcare Partners.
Will Leading Pharma IPO soon?
No public IPO plans have been announced for Leading Pharma.
How can I track Leading Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Leading Pharma's shares on secondary markets.